People with primary sclerosing cholangitis (PSC) have a six times higher risk of cancer affecting the large intestine or…
Patricia Inacio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inacio, PhD
CHOLESTASIS
NewsSevere ICP raises risk in twin pregnancy, study finds
Severe intrahepatic cholestasis of pregnancy (ICP) significantly raises the risks of adverse outcomes in twin pregnancies, according to a…
BILIARY ATRESIA
NewsAbnormal amino acid profile seen in biliary atresia infants after birth
The blood levels of four amino acids, the building blocks of proteins, are significantly elevated in infants with biliary…
CHOLESTASIS
NewsCase study supports efficacy of biliary diversion surgery for PFIC4
Biliary diversion surgery — which can be used in patients with bile duct problems — successfully reduced markers of liver…
Intrahepatic cholestasis of pregnancy (ICP), the most common pregnancy-related liver disease, is significantly linked to higher rates of several…
CHOLESTASIS
NewsCase study supports safety, efficacy of liver transplant for PFIC3
A 3-year-old boy with progressive familial intrahepatic cholestasis type 3 (PFIC3) was safety and effectively treated with a liver transplant…
CHOLANGITIS
NewsEMA committee recommends Iqirvo approval for PBC in Europe
A European Medicines Agency (EMA) committee has recommended the approval of Ipsen‘s Iqirvo (elafibranor) as a second-line therapy for…
FATTY LIVER DISEASE
NewsPoor sleep quality ID’d as key risk factor for fatty liver disease
Poor sleep quality — noted by researchers as increasingly common in modern society — is significantly linked to a higher…
World Hepatitis Day, marked annually on July 28, seeks to raise awareness and help efforts to end viral hepatitis,…
The U.S. Food and Drug Administration (FDA) has approved Vir Biotechnology’s request to conduct clinical testing in the U.S. of…